All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F20%3A00524906" target="_blank" >RIV/67985823:_____/20:00524906 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.1016/j.cell.2020.02.016" target="_blank" >https://doi.org/10.1016/j.cell.2020.02.016</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.cell.2020.02.016" target="_blank" >10.1016/j.cell.2020.02.016</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors

  • Original language description

    Using untargeted metabolomics (n = 1,162 subjects), the plasma metabolite (m/z = 265.1188) phenylacetylglutamine (PAGln) was discovered and then shown in an independent cohort (n = 4,000 subjects) to be associated with cardiovascular disease (CVD) and incident major adverse cardiovascular events (myocardial infarction, stroke, or death). A gut microbiota-derived metabolite, PAGln, was shown to enhance platelet activation-related phenotypes and thrombosis potential in whole blood, isolated platelets, and animal models of arterial injury. Functional and genetic engineering studies with human commensals, coupled with microbial colonization of germ-free mice, showed the microbial porA gene facilitates dietary phenylalanine conversion into phenylacetic acid, with subsequent host generation of PAGln and phenylacetylglycine (PAGly) fostering platelet responsiveness and thrombosis potential. Both gain- and loss-of-function studies employing genetic and pharmacological tools reveal PAGln mediates cellular events through G-protein coupled receptors, including alpha 2A, alpha 2B, and beta 2-adrenergic receptors. PAGln thus represents a new CVD-promoting gut microbiota-dependent metabolite that signals via adrenergic receptors.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Cell

  • ISSN

    0092-8674

  • e-ISSN

  • Volume of the periodical

    180

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    16

  • Pages from-to

    862-877

  • UT code for WoS article

    000519189800008

  • EID of the result in the Scopus database

    2-s2.0-85080144111